• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Allergy Immunoassay Brief

$3,000.00 – $6,000.00

Clear
SKU: 21-034 Category: Diagnostics Market Research Tags: ACTH, antibiotics, chemicals in plants, cosmetics, COVID-19, drugs, dust molds, eggs, estradiol, folic acid, food, insulin, microbes, milk, peanuts, penicillin, pertussis, POC, poison ivy, pollens, shellfish, Telehealth, tetracycline, thiamine, typhoid, Vaccines, venoms, vitamins Pages: 53
  • Description
  • Table of Contents
  • Latest reports

Description

Allergies are a number of conditions that are caused by hypersensitivity to a substance in the environment. Allergies can run the gamut of seasonal nuisances to life-threatening ordeals. Allergy statistics show that these conditions are constantly present in lives and are not going away.

Factors contributing to allergies worldwide include:

  • Environmental pollution
  • Changing lifestyles and dietary patterns
  • Indoor pollution

An individual who is overly reactive to an antigen that is tolerated by most others is said to be hypersensitive (allergic).  Whenever and allergic reaction occurs, there is tissue injury.  The antigens that induce an allergic reaction are called allergens. Common allergens include certain foods (milk, peanuts, shellfish, eggs, etc.), antibiotics (penicillin, tetracycline), vitamins (thiamine, folic acid), drugs (insulin, ACTH, estradiol), vaccines (pertussis, typhoid), venoms (honeybee, wasp, snake), cosmetics, chemicals in plants (poison ivy, pollens, dust molds), iodine-containing dyes used in certain x-ray procedures, and even microbes.

In recent years there has been an increase in demand for technologically advanced products and rapid detection of allergens. Food allergies can trigger swelling, hives, nausea, fatigue, and more. It may take a while for a person to realize that they have a food allergy. Seasonal allergies (typically referred to as hay fever) can mimic those of a cold including congestion, runny nose and swollen eyes. Severe allergies can cause anaphylaxis which is a life-threatening emergency that can lead to breathing difficulties, lightheadedness and loss of consciousness.

Scope and Methodology

Kalorama Information’s Allergy Immunoassay Brief has a geographic scope that is worldwide with information for specific geographical regions, especially the U.S., world allergy demographics, and other general issues affecting the market. The market summary includes total market values, market analysis by region, and test segment. Additionally, key company profiles are included.  The market does not include services for allergy immunoassay testing.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For the purpose of this study, Kalorama Information conducted interviews with over 10 industry officials, consultants, health care providers, and government personnel.  These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report.  Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests excluding services.  The base year for data was 2021. Compound annual growth rates (CAGRs) are provided for 2021-2026 periods. The forecasted market analysis for 2021-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.

 

Table of Contents

CHAPTER 1: EXECUTIVE SUMMARY

  • INTRODUCTION
  • SCOPE AND METHODOLOGY
  • SIZE AND GROWTH OF THE MARKET
      • Table 1-1: Allergy Immunoassay Market Analysis 2021-2026 ($ millions)
  • KEY ISSUES AND TRENDS AFFECTING THE MARKET
  • COMPETITIVE OUTLOOK
  • CONCLUSION HIGHLIGHTS
    • Conclusion 1: Skin patch tests compete with allergy immunoassays
    • Conclusion 2: Biotin Interference
    • Conclusion 3: Testing needs to be cost effective but precise to identify allergy diseases
    • Conclusion 4: Sophistication in testing is leading to more automated effective testing
    • Conclusion 5: Cross-reactive Carbohydrate Determinant

CHAPTER 2: INTRODUCTION AND OVERVIEW

  • ALLERGIES
    • Type I – Anaphylaxis
    • Type II -Cytotoxic Reactions
    • Type III- Immune Complex
    • Type IV – Cell Mediated
  • ALLERGY TESTING
      • Figure 2-1: IgE-mediated Hypersensitivity Reaction Pathway
  • PREVALENCE AND DEMOGRAPHICS OF ALLERGIES

CHAPTER 3: EMERGING TRENDS

  • COVID-19
  • PATIENT ENGAGEMENT/PATIENT-CENTERED HEALTHCARE
  • TELEHEALTH
  • INNOVATING POC
      • Table 3-1: Selected POC Test Innovations
      • Table 3-2: Selected POC Immunoassay Test Platforms
  • AUTOMATED ALLERGY DIAGNOSTIC PLATFORMS
  • CROSS-REACTIVE CARBOHYDRATE DETERMINANT
  • BIOTIN INTERFERENCE
      • Table 3-3: Biotin-free Offerings Currently on the Market

CHAPTER 4: MARKET PARTICIPANTS

  • AESKU. DIAGNOSTICS GMBH & CO KG
      • Table 4-1: AESKU Corporate Summary
    • Company Overview
  • ALPCO
      • Table 4-2: ALPCO Corporate Summary
    • Company Overview
  • BINDING SITE GROUP LTD. (THE)
      • Table 4-3: Binding Site Corporate Summary
    • Company Overview
  • BIOCHECK, INC.
      • Table 4-4: BioCheck Corporate Summary
    • Company Overview
  • BIOMERICA, INC.
      • Table 4-5: Biomerica Corporate Summary
    • Company Overview
      • Table 4-6: Biomerica Corporation Revenue (2017-2020) ($ millions)
  • BIO-RAD LABORATORIES INC.
      • Table 4-7: Bio-Rad Labs Corporate Summary
    • Company Overview
      • Table 4-8: Bio-Rad Corporation Revenue (2017-2020) ($ millions)
  • DIASYS DIAGNOSTIC SYSTEMS GMBH
      • Table 4-9: DiaSys Diagnostic Systems Corporate Summary
    • Company Overview
  • EUROIMMUN AG
      • Table 4-10: EUROIMMUN Corporate Summary
    • Company Overview
  • HOB BIOTECH GROUP CORP. LTD.
      • Table 4-11: HOB Biotech Corporate Summary
    • Company Overview
  • HYCOR BIOMEDICAL
      • Table 4-12: Hycor Biomedical Corporate Summary
    • Company Overview
  • IMMUNODIAGNOSTIC SYSTEMS HOLDINGS LTD
      • Table 4-13: Immunodiagnostics Systems Corporate Summary
    • Company Overview
  • MINARIS MEDICAL AMERICA
      • Table 4-14: Minaris Medical Corporate Summary
    • Company Overview
  • OMEGA
      • Table 4-15: Omega Corporate Summary
    • Company Overview
  • ROMER LABS, INC
      • Table 4-16: Romer Labs Corporate Summary
    • Company Overview
  • SIEMENS HEALTHINEERS GMBH
      • Table 4-17: Siemens Healthineers Corporate Summary
    • Company Overview
      • Table 4-18: Siemens Healthineers (2017-2020) ($ millions)
  • THERMO FISHER SCIENTIFIC
      • Table 4-19: Thermo Fisher Corporate Summary
    • Company Overview
      • Table 4-20: Thermo Fisher Corporation Revenue (2017-2020) ($ millions)
  • TOSOH BIOSCIENCE
      • Table 4-21: Tosoh Bioscience Corporate Summary
    • Company Overview

CHAPTER 5: MARKET ANALYSIS

  • MARKET OVERVIEW
      • Table 5-1: Allergy Immunoassay Market Analysis 2021-2026($ millions)
  • MARKET BY REGION
      • Table 5-2: Allergy Immunoassay Market by Region 2021
  • MARKET BY SEGMENT
      • Table 5-3: Allergy Immunoassay Market Revenues by Segment Type 2021 (in $millions)
      • Table 5-4: Allergy Immunoassay Market Segment Type by Percent 2021
  • COMPETITIVE ANALYSIS
    • Thermo Fisher
    • Siemens Healthineers
    • Minaris Medical
    • EUROIMMUN
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

    $2,625.00 – $5,250.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    Synthetic Blood Substitutes and Blood Products – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    $4,995.00 – $9,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
In Vitro Diagnostics (IVD) Market in China, 2021IVD Market Brief Update
Scroll to top